The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke
Abstract
Background and Purpose—A potentially dangerous side effect associated with tissue plasminogen activator (tPA) use is cerebral hemorrhage. We have focused on developing drugs that could be administered with tPA to reduce the rate of hemorrhage. Since recent studies suggest that various matrix metalloproteinases (MMPs) are important in tumor necrosis factor-α production and membrane and vessel remodeling after ischemia, we investigated whether MMP inhibition affected the rate of hemorrhage and infarct production in the absence or presence of tPA treatment. Methods—We occluded the middle cerebral artery of New Zealand White rabbits with radiolabeled blood clots. Five minutes after embolization, we administered either the MMP inhibitor BB-94 (30 mg/kg SC) or its vehicle. Additional groups received BB-94 or vehicle in combination with tPA, administered 60 minutes after embolization (3.3 mg/kg tPA). After 48 hours, the rabbits were killed and brains were removed, immersion fixed for 1 week in 4% paraformaldehyde, and then cut into 5-mm coronal sections that were examined for the presence of hemorrhage, infarcts, and recanalization. Results—Hemorrhage after embolic stroke was detected in 24% of the control group. tPA induced macroscopically visible hemorrhage in 77% of the tPA-treated group. The rabbits treated with BB-94 had an 18% incidence of hemorrhage (P>0.05 compared with control). However, when the combination of BB-94 and tPA was administered to rabbits, there was only a 41% incidence of hemorrhage (compared with 77% in the tPA group;P<0.05). Both tPA and BB-94/tPA were similarly effective at lysing clots, at 49% and 35% (P<0.05), respectively, compared with the 5% rate of lysis in the control group. There was a trend for a reduction in the number of infarcts, but it did not reach statistical significance. Conclusions—Our data suggest that MMP inhibition attenuates mechanisms involved in tPA-induced hemorrhage. This novel form of combination therapy may show promise as a treatment strategy for acute stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
The Harvard Cooperative Stroke Registry: A prospective registry
Mohr, J. P., Caplan, L. R., Melski, J. W., Goldstein, R. J., Duncan, G. W., Kistler, J. P., Pessin, M. S., & Bleich, H. L. (1978) · Neurology · doi:10.1212/wnl.28.8.754 · Cited by 1,172
Romanic, A. M., White, R. F., Arleth, A. J., Ohlstein, E. H., & Barone, F. C. (1998) · Stroke · doi:10.1161/01.str.29.5.1020 · Cited by 739
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
McGeehan, G. M., Becherer, J. D., Bast, R. C., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) · Nature · doi:10.1038/370558a0 · Cited by 561
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
Heo, J. H., Lucero, J., Abumiya, T., Koziol, J. A., Copeland, B. R., & del Zoppo, G. J. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00005 · Cited by 547
Matrix Metalloproteinases in Cerebrovascular Disease
Mun-Bryce, S., & Rosenberg, G. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00001 · Cited by 348
Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat
Rosenberg, G. A., & Navratil, M. (1997) · Neurology · doi:10.1212/wnl.48.4.921 · Cited by 305
Cited by
Lees, K. R., Bluhmki, E., von Kummer, R., Brott, T. G., Toni, D., Grotta, J. C., Albers, G. W., Kaste, M., Marler, J. R., Hamilton, S. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60491-6 · Cited by 2,184
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke
Yang, C., Hawkins, K. E., Doré, S., & Candelario-Jalil, E. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00136.2018 · Cited by 871
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications
Simard, J. M., Kent, T. A., Chen, M., Tarasov, K. V., & Gerzanich, V. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70055-8 · Cited by 794
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yang, Y., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.608257 · Cited by 789
Inflammation after Intracerebral Hemorrhage
Wang, J., & Doré, S. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600403 · Cited by 651
Preclinical and clinical research on inflammation after intracerebral hemorrhage
Wang, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.08.001 · Cited by 602
Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
Rosenberg, G. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70016-x · Cited by 594
Molecular pathophysiology of cerebral edema
Stokum, J. A., Gerzanich, V., & Simard, J. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15617172 · Cited by 587
Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribó, M., Quintana, M., & Alvarez-Sabín, J. (2003) · Circulation · doi:10.1161/01.cir.0000046451.38849.90 · Cited by 555
Turner, R. J., & Sharp, F. R. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00056 · Cited by 533
Candelario-Jalil, E., Yang, Y., & Rosenberg, G. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.025 · Cited by 527
Gidday, J. M., Gasche, Y. G., Copin, J.-C., Shah, A. R., Perez, R. S., Shapiro, S. D., Chan, P. H., & Park, T. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01275.2004 · Cited by 483
Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Wang, X., Lee, S.-R., Arai, K., Lee, S.-R., Tsuji, K., Rebeck, G. W., & Lo, E. H. (2003) · Nature Medicine · doi:10.1038/nm926 · Cited by 460
Early blood–brain barrier disruption in human focal brain ischemia
Latour, L. L., Kang, D., Ezzeddine, M. A., Chalela, J. A., & Warach, S. (2004) · Annals of Neurology · doi:10.1002/ana.20199 · Cited by 451
Sumii, T., & Lo, E. H. (2002) · Stroke · doi:10.1161/hs0302.104542 · Cited by 423
Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A. Y., & Lipton, S. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1563-05.2005 · Cited by 417
Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Lakhan, S. E., Kirchgessner, A., Tepper, D., & Leonard, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00032 · Cited by 384
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371
Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases
Power, C., Henry, S., Del Bigio, M. R., Larsen, P. H., Corbett, D., Imai, Y., Yong, V. W., & Peeling, J. (2003) · Annals of Neurology · doi:10.1002/ana.10553 · Cited by 363
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. (2007) · Neurosurgical Focus · doi:10.3171/foc.2007.22.5.5 · Cited by 357
Montaner, J., Alvarez-Sabín, J., Molina, C., Anglés, A., Abilleira, S., Arenillas, J., González, M. A., & Monasterio, J. (2001) · Stroke · doi:10.1161/01.str.32.8.1759 · Cited by 350
Wang, X., Tsuji, K., Lee, S.-R., Ning, M., Furie, K. L., Buchan, A. M., & Lo, E. H. (2004) · Stroke · doi:10.1161/01.str.0000143219.16695.af · Cited by 334
Pathophysiology of Stroke: Lessons from Animal Models
Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043966.46964.e6 · Cited by 325
Wang, J., & Tsirka, S. E. (2005) · Brain · doi:10.1093/brain/awh489 · Cited by 321
Lo, E. H., Wang, X., & Cuzner, M. L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10270 · Cited by 310
Montaner, J., Alvarez-Sabín, J., Molina, C. A., Anglés, A., Abilleira, S., Arenillas, J., & Monasterio, J. (2001) · Stroke · doi:10.1161/hs1201.99512 · Cited by 298
Liou, A. K. F., Clark, R. S., Henshall, D. C., Yin, X.-M., & Chen, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00005-4 · Cited by 297
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic
Yepes, M., Roussel, B. D., Ali, C., & Vivien, D. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.006 · Cited by 286
Macrae, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01398.x · Cited by 274
Pfefferkorn, T., & Rosenberg, G. A. (2003) · Stroke · doi:10.1161/01.str.0000083051.93319.28 · Cited by 272
Justicia, C., Panés, J., Solé, S., Cervera, Á., Deulofeu, R., Chamorro, Á., & Planas, A. M. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090680.07515.c8 · Cited by 262
Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 242
“Matrix metalloproteinases, a family of enzymes with over 20 members identified to date, have been shown to be involved in the regulation of vascular integrity and have been implicated in a variety of vasculopathies, including hemorrhagic transformation after cerebral ischemia [55, 63, 120].”
BackgroundMetzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 223
Ishrat, T., Sayeed, I., Atif, F., Hua, F., & Stein, D. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.023 · Cited by 159
Zechariah, A., ElAli, A., & Hermann, D. M. (2010) · Stroke · doi:10.1161/strokeaha.109.574418 · Cited by 84
Jia, L., Chopp, M., Zhang, L., Lu, M., & Zhang, Z. (2010) · Stroke · doi:10.1161/strokeaha.110.586198 · Cited by 62
Metadata
- Authors
- Lapchak, P. A., Chapman, D. F., & Zivin, J. A.
- Venue
- Stroke
- Published
- 2000-12
- Volume
- 31
- Issue
- 12
- Pages
- 3034-3040
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2123648780
- Cited by
- 339
- References
- 28
- FWCI
- 15.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.